The Centers for Disease Control and Prevention and Food and Drug Administration have lifted a 10-day pause on the Johnson & Johnson vaccine, but will issue a fact sheet to medical providers warning them of the potential for extremely rare but serious blood clots.
There are now 31 states, including New York and New Jersey, that have announced plans to resume the use of the Johnson & Johnson vaccine. There have been concerns following 15 verified blood clot cases out of 8 million J&J shots administered. That’s about one case per 500,000 vaccines. After pausing the use of the vaccine early last week, the FDA and the CDC announced Friday that the benefits outweigh the risks.
Public health experts from the federal government and our own independent State task force have reviewed the data & reaffirmed that the use of the Johnson & Johnson vaccine can resume.
NYS will resume administration of J&J effective immediately. pic.twitter.com/abG0xjvdRd
— Andrew Cuomo (@NYGovCuomo) April 24, 2021
